Menu
Recruiting NCT07731295

iPAWS: Improving Pain Management After Wisdom Tooth Extraction Surgery

No phase Interventional Pain, Postoperative Substance Use

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: iPAWS, Educational Materials.
Who it may be relevant to
Registry conditions: Pain, Postoperative, Substance Use. Basic parameters: 15 years — 20 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This is a clinical trial that will evaluate the feasibility and acceptability of a virtual brief program for adolescents and young adults undergoing wisdom tooth extraction and their parents. The program aims to teach youth safe and effective ways to manage post-surgical pain as well as decrease risky health behaviors.

Interventions

  • Behavioral iPAWS
    The brief intervention (named iPAWS) will be an integration of evidence-based brief interventions for AYA SU (e.g. MET-CBT) and acute pain coping (CBT). The intervention is brief, readily accessible, developmentally tailored, applicable to single and poly-SU and scalable to other acutely painful procedures to meet the need for effective, accessible, and scalable SU interventions at key entry points of clinical care.
  • Other Educational Materials
    Participants will be given a digital copy of a brochure from the American Dental Association on "Wisdom Teeth Management" (included in attachments). The investigator will also mail the participant a hard copy of the brochure, if requested.

Primary outcome measures

  • Number of participants who complete the active treatment phase (feasibility) [Time frame: End of active treatment phase (6 weeks)]
  • Number of participants who rate their treatment experience in the "satisfactory" or "highly satisfactory" range on the Client Satisfaction Questionnaire (Acceptability) [Time frame: End of active treatment phase (6 weeks)]
Secondary outcome measures (6)
  • Number of cannabis use days [Time frame: Last 3 weeks of active treatment phase (weeks 4-6)]
  • Pain intensity [Time frame: Last 3 weeks of active treatment phase (weeks 4-6)]
  • Substance use craving [Time frame: Last 3 weeks of active treatment phase (weeks 4-6)]
  • Abstinent days [Time frame: Last 3 weeks of active treatment phase (weeks 4-6)]
  • Pain intereference [Time frame: Last 3 weeks of active treatment phase (weeks 4-6)]
  • Pain coping strategies [Time frame: Last 3 weeks of active treatment phase (weeks 4-6)]

Eligibility criteria

Inclusion criteria

  • Ages 15 to 20 years
  • Undergoing wisdom tooth extraction for the first time
  • Able to read simple English
  • \*Endorse cannabis use at least two days per week on average in the past 28 days

\*The investigator aims to recruit at least 50 participants who are using cannabis at least two days per week in the past 28 days on average and will recruit up to 100 additional participants who use other substances, use cannabis at a lesser intensity, or do not use any substances.

  • (Parent/Guardian only) - Have a child who is undergoing wisdom tooth surgery and is participating in the study

Exclusion criteria

\- N/A

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Brown University Center for Alcohol and Addiction Studies — Providence

Identifiers

NCT: NCT07731295 · STUDY00000662 · 1K23DA053411

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗